Logo image of BRYN.DE

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR

465.05  -1.1 (-0.24%)

Fundamental Rating

5

Overall BRYN gets a fundamental rating of 5 out of 10. We evaluated BRYN against 47 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BRYN had positive earnings in the past year.
BRYN had a positive operating cash flow in the past year.
Of the past 5 years BRYN 4 years were profitable.
BRYN had a positive operating cash flow in each of the past 5 years.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

BRYN's Return On Assets of 7.71% is fine compared to the rest of the industry. BRYN outperforms 74.51% of its industry peers.
BRYN's Return On Equity of 13.70% is fine compared to the rest of the industry. BRYN outperforms 66.67% of its industry peers.
The Return On Invested Capital of BRYN (4.68%) is better than 60.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRYN is significantly below the industry average of 10.10%.
The last Return On Invested Capital (4.68%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.71%
ROE 13.7%
ROIC 4.68%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

BRYN's Profit Margin of 23.96% is fine compared to the rest of the industry. BRYN outperforms 76.47% of its industry peers.
In the last couple of years the Profit Margin of BRYN has declined.
Looking at the Operating Margin, with a value of 16.41%, BRYN is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
BRYN's Operating Margin has improved in the last couple of years.
BRYN's Gross Margin of 16.21% is in line compared to the rest of the industry. BRYN outperforms 41.18% of its industry peers.
In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 16.41%
PM (TTM) 23.96%
GM 16.21%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
BRYN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
BRYN has a Altman-Z score of 1.36. This is comparable to the rest of the industry: BRYN outperforms 43.14% of its industry peers.
The Debt to FCF ratio of BRYN is 10.74, which is on the high side as it means it would take BRYN, 10.74 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.74, BRYN perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.19, BRYN is doing good in the industry, outperforming 68.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.74
Altman-Z 1.36
ROIC/WACC1.45
WACC3.23%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

A Current Ratio of 1.18 indicates that BRYN should not have too much problems paying its short term obligations.
The Current ratio of BRYN (1.18) is comparable to the rest of the industry.
BRYN has a Quick Ratio of 1.18. This is a bad value and indicates that BRYN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, BRYN is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.94
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

4

3. Growth

3.1 Past

BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.98%, which is quite impressive.
Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
BRYN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.91%.
BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)27.98%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%71.86%
Revenue 1Y (TTM)1.91%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%1.65%

3.2 Future

BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.27% yearly.
Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 6.94% on average per year.
EPS Next Y-3.52%
EPS Next 2Y0.48%
EPS Next 3Y1.32%
EPS Next 5Y2.27%
Revenue Next Year0.01%
Revenue Next 2Y2.23%
Revenue Next 3Y0.14%
Revenue Next 5Y6.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100B 200B 300B 400B 500B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10K 20K 30K

8

4. Valuation

4.1 Price/Earnings Ratio

BRYN is valuated cheaply with a Price/Earnings ratio of 0.02.
Compared to the rest of the industry, the Price/Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.78. BRYN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (21.32), we can say BRYN is valued rather cheaply.
Industry RankSector Rank
PE 0.02
Fwd PE 0.02
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaper than 98.04% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.07
EV/EBITDA 1.02
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K

4.3 Compensation for Growth

The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.48%
EPS Next 3Y1.32%

0

5. Dividend

5.1 Amount

BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (4/25/2025, 7:00:00 PM)

465.05

-1.1 (-0.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-22 2025-02-22/bmo
Earnings (Next)05-05 2025-05-05
Inst Owners33.43%
Inst Owner ChangeN/A
Ins Owners37.69%
Ins Owner ChangeN/A
Market Cap669.67M
Analysts80
Price Target449.87 (-3.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.2%
Min EPS beat(2)-10.41%
Max EPS beat(2)42.8%
EPS beat(4)3
Avg EPS beat(4)16.14%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)12.04%
EPS beat(12)9
Avg EPS beat(12)10.27%
EPS beat(16)12
Avg EPS beat(16)9.92%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-7.69%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)0.24%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)5
Avg Revenue beat(12)-0.45%
Revenue beat(16)6
Avg Revenue beat(16)-0.71%
PT rev (1m)-10.67%
PT rev (3m)-9.64%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-6.01%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)3.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.02
P/S 0
P/FCF 0.07
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 1.02
EPS(TTM)29051.43
EY6246.95%
EPS(NY)28027.6
Fwd EY6026.79%
FCF(TTM)7102.81
FCFY1527.32%
OCF(TTM)18706
OCFY4022.36%
SpS227119.47
BVpS397067.89
TBVpS323903
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 7.71%
ROE 13.7%
ROCE 5.79%
ROIC 4.68%
ROICexc 4.9%
ROICexgc 5.89%
OM 16.41%
PM (TTM) 23.96%
GM 16.21%
FCFM 3.13%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.74
Debt/EBITDA 1.69
Cap/Depr 147.62%
Cap/Sales 5.11%
Interest Coverage 12.34
Cash Conversion 41.46%
Profit Quality 13.05%
Current Ratio 1.18
Quick Ratio 0.94
Altman-Z 1.36
F-Score4
WACC3.23%
ROIC/WACC1.45
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.98%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%71.86%
EPS Next Y-3.52%
EPS Next 2Y0.48%
EPS Next 3Y1.32%
EPS Next 5Y2.27%
Revenue 1Y (TTM)1.91%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%1.65%
Revenue Next Year0.01%
Revenue Next 2Y2.23%
Revenue Next 3Y0.14%
Revenue Next 5Y6.94%
EBIT growth 1Y26.05%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-37.82%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%